645 related articles for article (PubMed ID: 33446268)
1. Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis.
Yamada Y; Harada M; Hara Y; Iwabuchi R; Hashimoto K; Yamamoto S; Kamijo Y
Arthritis Res Ther; 2021 Jan; 23(1):28. PubMed ID: 33446268
[TBL] [Abstract][Full Text] [Related]
2. Anti-cytokine targeted therapies for ANCA-associated vasculitis.
Bala MM; Malecka-Massalska TJ; Koperny M; Zajac JF; Jarczewski JD; Szczeklik W
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD008333. PubMed ID: 32990324
[TBL] [Abstract][Full Text] [Related]
3. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Beketova TV
Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
[TBL] [Abstract][Full Text] [Related]
5. ANCA associated vasculitis (AAV): a review for internists.
Yaseen K; Mandell BF
Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
[TBL] [Abstract][Full Text] [Related]
6. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
Singh D; Sukumaran S
Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway.
Nilsen AT; Karlsen C; Bakland G; Watts R; Luqmani R; Koldingsnes W
Rheumatology (Oxford); 2020 Sep; 59(9):2316-2324. PubMed ID: 31859355
[TBL] [Abstract][Full Text] [Related]
8. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
[TBL] [Abstract][Full Text] [Related]
9. [Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China].
Tian XP; Zhao LK; Jiang ZY; Wang Y; Huang CB; Zhao Y
Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1128-1135. PubMed ID: 36207967
[TBL] [Abstract][Full Text] [Related]
10. [ANCA-associated vasculitis].
Krasselt ML; Holle JU
Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
12. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and electrophysiological characteristics and treatment outcomes of anti-neutrophil cytoplasmic antibody ANCA-associated vasculitic neuropathy].
Li YF; Li M; Yang F; Wang HF; Xu F; Chen SY; Sun B; Chen ZH; Huang XS
Zhonghua Nei Ke Za Zhi; 2024 Apr; 63(4):386-393. PubMed ID: 38561284
[No Abstract] [Full Text] [Related]
14. Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.
Pecher AC; Henes M; Henes JC
Arch Gynecol Obstet; 2023 Aug; 308(2):379-385. PubMed ID: 36104505
[TBL] [Abstract][Full Text] [Related]
15. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
16. Monitoring disease activity in antineutrophil antibody-associated vasculitis.
Scurt FG; Hirschfeld V; Schubert L; Mertens PR; Chatzikyrkou C
Scand J Immunol; 2023 Jul; 98(1):e13284. PubMed ID: 37132459
[TBL] [Abstract][Full Text] [Related]
17. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study.
Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2024 Jan; 43(1):367-376. PubMed ID: 37530864
[TBL] [Abstract][Full Text] [Related]
19. Novel Therapies for ANCA-associated Vasculitis.
Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
[TBL] [Abstract][Full Text] [Related]
20. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]